Skip to main content

ADVERTISEMENT

James E. Tcheng, MD

Review
08/01/2008
Part II of III - Continued TABLE 3 KEY (continued) 2) Unfractionated heparin(UFH) can be used as an alternative to enoxaparin. If UFH is used in the setting of PCI, activated clotting time (ACT) should be followed to achieve an appropriate...
Part II of III - Continued TABLE 3 KEY (continued) 2) Unfractionated heparin(UFH) can be used as an alternative to enoxaparin. If UFH is used in the setting of PCI, activated clotting time (ACT) should be followed to achieve an appropriate...
Part II of III -...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
A total of 5,225 patients were enrolled in the PARAGON B trial. Among these patients, the type of heparin used was known in 5,200 (99.5%). The median duration of therapy was 72.8 hours for UFH and 79.7 hours for LMWH. LMWH was used in about...
A total of 5,225 patients were enrolled in the PARAGON B trial. Among these patients, the type of heparin used was known in 5,200 (99.5%). The median duration of therapy was 72.8 hours for UFH and 79.7 hours for LMWH. LMWH was used in about...
A total of 5,225 patients were...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Case description. A 25-year-old Filipino male without any prior medical history presented to an outside hospital 1 hour after the acute onset of severe substernal chest pain that developed while playing a vigorous game of professional...
Case description. A 25-year-old Filipino male without any prior medical history presented to an outside hospital 1 hour after the acute onset of severe substernal chest pain that developed while playing a vigorous game of professional...
Case description. A 25-year-old...
08/01/2008
Journal of Invasive Cardiology
Clinical Editor's Corner
11/27/2018
I asked for words of wisdom from our cath lab expert group regarding their experience with same-day discharge at their center. What are the obstacles to SDD? Who are the champions and why are we not doing it more?
I asked for words of wisdom from our cath lab expert group regarding their experience with same-day discharge at their center. What are the obstacles to SDD? Who are the champions and why are we not doing it more?
I asked for words of wisdom from...
11/27/2018
Cath Lab Digest
08/01/2008
Profound advancements in the management of acute coronary syndromes (ACS) have been realized in recent years. Initial medical therapy for non-ST segment elevation ACS has evolved to include the use of the combined treatment modalities of...
Profound advancements in the management of acute coronary syndromes (ACS) have been realized in recent years. Initial medical therapy for non-ST segment elevation ACS has evolved to include the use of the combined treatment modalities of...
Profound advancements in the...
08/01/2008
Journal of Invasive Cardiology
Clinical Editor's Corner
07/01/2015
“We have been referred a patient with a recurrent VSD [ventricular septal defect] after surgical closure in the remote past.  She has a history of anaphylaxis despite proper premedication for contrast media allergy during her recent cath....
“We have been referred a patient with a recurrent VSD [ventricular septal defect] after surgical closure in the remote past.  She has a history of anaphylaxis despite proper premedication for contrast media allergy during her recent cath....
“We have been referred a patient...
07/01/2015
Cath Lab Digest
08/01/2008
Percutaneous coronary intervention (PCI) is an effective treatment for myocardial ischemia in patients with coronary artery disease. More than one million PCI procedures were performed worldwide in 1998.1 A major limitation of percutaneous...
Percutaneous coronary intervention (PCI) is an effective treatment for myocardial ischemia in patients with coronary artery disease. More than one million PCI procedures were performed worldwide in 1998.1 A major limitation of percutaneous...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Cath Lab Systems
01/11/2010
A behind-the-scenes look with three superusers. Theresa DeMuro (Holding) and Wanda Cooley (Cath Labs) Tell us about your previous hemodynamic system and why you changed to the Xper Information Management system. Theresa (Holding): We...
A behind-the-scenes look with three superusers. Theresa DeMuro (Holding) and Wanda Cooley (Cath Labs) Tell us about your previous hemodynamic system and why you changed to the Xper Information Management system. Theresa (Holding): We...
A behind-the-scenes look with...
01/11/2010
Cath Lab Digest
08/01/2008
Case report. A 70-year-old woman with a history of smoking, hypertension and hyperlipidemia was referred for evaluation of exertional angina that had developed over the preceding 6 months. Thirteen years earlier, she had undergone balloon...
Case report. A 70-year-old woman with a history of smoking, hypertension and hyperlipidemia was referred for evaluation of exertional angina that had developed over the preceding 6 months. Thirteen years earlier, she had undergone balloon...
Case report. A 70-year-old woman...
08/01/2008
Journal of Invasive Cardiology
10/05/2015
The composition and scope of practice of the sheath management team is of concern to Dr. David Rizik, who asked our expert colleagues in the cath lab about sheath management in their hospitals.   
The composition and scope of practice of the sheath management team is of concern to Dr. David Rizik, who asked our expert colleagues in the cath lab about sheath management in their hospitals.   
The composition and scope of...
10/05/2015
Cath Lab Digest